(Updated - July 9, 2024 7:59 AM EDT)

UBS analyst Joshua Spector upgraded Chemours (NYSE: CC) from Neutral to ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE